Company intelligence / Profile preview
Sushma
- Ownership
- Private
- Development stage
- Other
Overview
Sushma Biotech is an Indian pharmaceutical company founded in 2018 that specializes in providing high-quality, affordable healthcare products. The company operates in the PCD (Propaganda Cum Distribution) franchise and third-party contract manufacturing sectors, utilizing WHO-GMP and GLP-certified production facilities. Its diverse product portfolio includes capsules, dry syrups, injections, powders, suspensions, syrups, and tablets distributed across a robust PAN-India network. Sushma Biotech focuses on collaborative partnerships and reliable logistics to ensure timely delivery and accessibility of essential medicines throughout India.
- Therapeutic areas
- ImmunologyNeurologyInfectious DiseasesCardiovascularEndocrinology
- Modalities
- Small molecule
- Industry
- Pharma
Drug pipeline
1 assetBeyond the preview
Go deeper on Sushma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sushma.